Table 2 Healthcare use in MCRC patients receiving XELOX or FOLFOX4
| Â | XELOX (n = 30) Mean no./person (SD) | FOLFOX4 (n = 30) Mean no./person (SD) |
|---|---|---|
Chemotherapy cycles | 7.3 (1.4) | 9.2 (2.8) |
Other drugs | 9.3 (5.8) | 12.4 (7.2) |
Hospital bed-days | 10.3 (5.2) | 33.2 (9.1) |
Outpatient clinic visits | 15.5 (3.4) | 16.5 (5.1) |
Laboratory investigations | 38.6 (11.2) | 37.3 (12.8) |
X-rays and scans | 4.3 (3.1) | 3.8 (2.5) |